Influence of Tryptophan Modification upon Digestion of Antithrombin III by Elastase

Summary

Chemical modification of tryptophan residues in antithrombin III by dimethyl (2-hydroxy-5-nitrobenzyl) sulfonium bromide (HNBSB) generates products with similar levels of modification (equivalent to 0.9 mole 2-hydroxy-5-nitrobenzyl [HNB] incorporated/mole of antithrombin III) but with high or low affinity for heparin-Sepharose. Upon digestion with pancreatic or neutrophil elastase the low affinity forms generate a product of molecular weight form (55 kDa) not seen in digests of native antithrombin III or modified forms with high affinity for heparin. When measured as loss of activity the obserued rate of digestion of the latter in the absence of heparin was more rapid than that of native antithrombin III. The differences in digestion are considered to be related to conformation at differences between the various forms.

• References

• 1 Björk I, Lindahl U. Mechanism of the anticoagulant action of heparin. Mol Cell Biochem 1982; 48: 161-187
• 2 Olson ST, Shore SD. Binding of high affinity heparin to antithrombin III Characteraation of the protein fluorescence enhancement. J Biol Chem 1981; 256: 11065-11082
• 3 Olson SI, Srinivarson KR, Bjork I, Shore ST. Binding of high affinity heparin to antithrombin II. Stopped flow kinetic studies of the binding interaction. J Biol Chem 1981 256. 11073-11079
• 4 Pomerantz MW, Owen WG. A catalytic role for heparin. Evidence for a ternary complex of heparin cofactor and heparin. Biochem Biophys Acta 1978 535. 6-72
• 5 Griffith MJ. Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin. J Biol Chem 1980 255. 10081-10090
• 6 Nesheim ME. A simple rate law that describes the kinetics of interaction between antithrombin III and thrombin. J Biol Chem 1983; 258: 14708-14717
• 7 Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin III-heparin cofactor. J Biol Chem 1973; 248: 6490-6505
• 8 Carrell RW, Travis J. cr1-antitrypsin and the serpins: variation and countervariation. Tiends Biochem Sci 1983; 10: 20-24
• 9 Carrell RW, Owen MC. Plakalbumin, alpha l-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature (London) 1985; 317: 730-732
• 10 Shan N, Scully MF, Ellis V, Kakkar VV. Influence of chemical modification of tryptophan residues on the properties of human antithrombin III. Thromb Res 1990; 57: 343-352
• 11 Scully MF, Kakkar VV. The anthiheparin effect of pentosan polysulphate. Investigation of a mechanism. Biochem J 1984; 218: 657-665
• 12 Denton J, Lewis WE, Nieuduszynski IA, Phelps CE. Fractionation of heparin using antithrombin III reversibly bound to conconavalin ASepharose. Analyt Biochem 1981; 118: 388-391
• 13 Blackburn MN, Sibley CC. The heparin binding site of antithrombin III. Evidence for a critical tryptophan residue. J Biol Chem 1980 255. 824-826
• 14 Horton HR, Koshland Jr PE. Dimethyl (2-hydroxy-5-nitrobenzyl) sulfonium salts and chemical modification of tryptophan residues. J Biol Chem 1972; 25: 468-442
• 15 Scully MF, Kakkar VV. Semi-micro and automated methods for the determination of thrombin, antithrombin and heparin cofactor using the chromogenic substrate, H-D-Phe-Pip-Arg-p-nitroanilide. Clin Chim Acta 1977; 79: 595-602
• 16 Downing MR, Bloom JW, Mann KG. Comparison of the inhibition of thrombin by three plasma protease inhibitors. Biochemistry 1978; 17: 2649-2653
• 17 Karp GI, Marcum JA, Rosenberg RD. The role of tryptophan residues in heparin-antithrombin interactions. Arch Biochem Biophys 1984; 233: 712-720
• 18 Jordan RE, Kilpatrick J, Nelson RM. Heparin promotes the inactivation of antithrombin by neutrophil elastase. Science 1987; 237: 777-779
• 19 Jordan RE, Nelson RM, Kilpatrick J, Nawgren JO, Esmon PC, Fournal MA. Inactivation of human antithrombin by neutrophil elastase. Kinetics of the heparin-dependent reaction. J Biol Chem 1989; 264: 10492-10500
• 20 Stein PE, Leslie AGW, Finch JI, Turnell WG, Mclaughlin PJ, Carrell RW. Crystal structure of ovalbumin as a model for the reactive centre of serpins. Nature 1990; 347: 99-102
• 21 Kress LS, Catanese JJ. Identification of the cleavage sites resulting from enzymatic inactivation of human antithrombin III by Crotalus adamanteus Proteinase II in the presence or absence of heparin. Biochemistry 1981; 20: 7432-7433
• 22 Molho-Sabatier R, Aiach M, Gaillard I, Fiessinger JN, Fischer AM, Chadeuf G, Clauser E. Molecular characteization of antithrombin III variants using polymerase chain reaction. J Clin Invest 1989; 84: 1236-1242
• 23 Einarrson R, Andersson L-O. Binding of human antithrombin III as studied by measurements of tryptophan fluorescence. Biochem Biophys Acta 1977; 490: 104-112
• 24 Björk I, Nordenman BJ. Acceleration of the reaction between thrombin and antithrombin III by non-stoichiometric amounts of heparin. Eur J Biochem 1976; 68: 507-511
• 25 Olson ST, Shore JD. Demonstration of a two step mechanism for inhibition of thrombin by antithrombin III and identification of the step affected by heparin. J Biol Chem 1982; 257: 1491-1495